These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11039761)

  • 1. Potential of gene therapy for treating osteogenesis imperfecta.
    Niyibizi C; Smith P; Mi Z; Robbins P; Evans C
    Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S126-33. PubMed ID: 11039761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo.
    Niyibizi C; Smith P; Mi Z; Phillips CL; Robbins P
    J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):84-91. PubMed ID: 11500956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy approaches for osteogenesis imperfecta.
    Niyibizi C; Wang S; Mi Z; Robbins PD
    Gene Ther; 2004 Feb; 11(4):408-16. PubMed ID: 14724682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches for skeletal gene therapy.
    Niyibizi C; Wallach CJ; Mi Z; Robbins PD
    Crit Rev Eukaryot Gene Expr; 2002; 12(3):163-73. PubMed ID: 12449341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
    Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
    Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition.
    Basel D; Steiner RD
    Genet Med; 2009 Jun; 11(6):375-85. PubMed ID: 19533842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in osteogenesis imperfecta.
    Cole WG
    Clin Orthop Relat Res; 2002 Aug; (401):6-16. PubMed ID: 12151877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OIM and related animal models of osteogenesis imperfecta.
    Shapiro JR; Mcbride DJ; Fedarko NS
    Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen (I) homotrimer potentiates the osteogenesis imperfecta (oim) mutant allele and reduces survival in male mice.
    Lee KJ; Rambault L; Bou-Gharios G; Clegg PD; Akhtar R; Czanner G; van 't Hof R; Canty-Laird EG
    Dis Model Mech; 2022 Sep; 15(9):. PubMed ID: 36106514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts.
    Dawson PA; Marini JC
    Nucleic Acids Res; 2000 Oct; 28(20):4013-20. PubMed ID: 11024182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele dependent silencing of collagen type I using small interfering RNAs targeting 3'UTR Indels - a novel therapeutic approach in osteogenesis imperfecta.
    Lindahl K; Kindmark A; Laxman N; Åström E; Rubin CJ; Ljunggren Ö
    Int J Med Sci; 2013; 10(10):1333-43. PubMed ID: 23983594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis imperfecta.
    Byers PH; Steiner RD
    Annu Rev Med; 1992; 43():269-82. PubMed ID: 1580589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta.
    Bonadio J; Saunders TL; Tsai E; Goldstein SA; Morris-Wiman J; Brinkley L; Dolan DF; Altschuler RA; Hawkins JE; Bateman JF
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7145-9. PubMed ID: 2402497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
    Deyle DR; Khan IF; Ren G; Wang PR; Kho J; Schwarze U; Russell DW
    Mol Ther; 2012 Jan; 20(1):204-13. PubMed ID: 22031238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects.
    Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ
    Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific gene silencing in osteogenesis imperfecta.
    Ljunggren Ö; Lindahl K; Rubin CJ; Kindmark A
    Endocr Dev; 2011; 21():85-90. PubMed ID: 21865757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenesis imperfecta: prospects for molecular therapeutics.
    Forlino A; Marini JC
    Mol Genet Metab; 2000; 71(1-2):225-32. PubMed ID: 11001814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.
    Oyama M; Tatlock A; Fukuta S; Kavalkovich K; Nishimura K; Johnstone B; Robbins PD; Evans CH; Niyibizi C
    Gene Ther; 1999 Mar; 6(3):321-9. PubMed ID: 10435082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.
    Willing MC; Cohn DH; Byers PH
    J Clin Invest; 1990 Jan; 85(1):282-90. PubMed ID: 2295701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.